Table II.
Variable | Observation group (%) | Control group (%) |
---|---|---|
Efficacy assessment (WHO) | 66.8 | 60.2 |
KPS | ||
Prior to treatment | 65.73±9.05 | 64.00±9.00.. |
Following treatment | 83.36±11.64 | 71.64±10.60 |
Phenotype of CIK cells prior to transfusion | ||
CD3+ | ||
Prior to culture | 56.76±4.54 | - |
Following culture | 94.67±4.46 | - |
CD3+CD56+ | ||
Prior to culture | 11.32±2.96 | - |
Following culture | 32.65±1.12 | - |
KPS, Karnofsky performance status; CIK, cytokine-induced killer.